Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 27.06B | 28.84B | 35.30B | 33.27B | 24.87B | 30.45B |
Gross Profit | 5.07B | 5.29B | 6.93B | 7.10B | 4.39B | 6.62B |
EBITDA | 527.50M | 485.00M | 2.16B | 2.62B | 749.00M | 2.21B |
Net Income | -1.36B | -1.29B | 648.00M | 1.28B | -232.00M | 883.00M |
Balance Sheet | ||||||
Total Assets | 18.16B | 30.06B | 31.90B | 31.13B | 28.57B | 28.13B |
Cash, Cash Equivalents and Short-Term Investments | 3.25B | 6.17B | 6.50B | 7.14B | 7.18B | 5.05B |
Total Debt | 2.63B | 2.26B | 1.96B | 1.76B | 960.00M | 1.20B |
Total Liabilities | 8.73B | 11.48B | 11.92B | 11.51B | 10.42B | 9.74B |
Stockholders Equity | 9.33B | 18.14B | 19.62B | 19.32B | 17.87B | 18.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -124.00M | -308.00M | -864.00M | 2.48B | -186.00M |
Operating Cash Flow | 0.00 | 552.00M | 256.00M | -550.00M | 3.78B | 904.00M |
Investing Cash Flow | 0.00 | -643.00M | -565.00M | -315.00M | -1.32B | -1.89B |
Financing Cash Flow | 0.00 | -370.00M | -470.00M | 540.00M | -344.00M | 434.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.07B | 9.48 | 2.26% | 2.63% | 268.28% | ||
80 Outperform | ¥15.43B | 8.80 | 2.31% | 20.91% | 18.64% | ||
73 Outperform | ¥12.56B | 9.95 | 3.72% | -6.96% | -1.72% | ||
67 Neutral | ¥12.54B | 19.86 | 0.67% | 2.16% | -16.86% | ||
65 Neutral | $10.75B | 15.65 | 5.18% | 1.92% | 3.09% | -27.41% | |
57 Neutral | ¥12.00B | 15.57 | 2.07% | 25.48% | ― | ||
54 Neutral | ¥12.68B | ― | 5.66% | -6.30% | 34.61% |